dose dense chemotherapy as front-line treatment for ovarian cancer - stephen welch
Published 1 year ago • 33 plays • Length 36:12Download video MP4
Download video MP3
Similar videos
-
6:20
dose-dense chemotherapy for ovarian cancer; adding bevacizumab
-
3:42
gynecologic oncology at asco 2022: athena–mono trial (rucaparib monotherapy) for ovarian cancer
-
15:49
update on immuno-oncology clinical trials in canada - stephen welch, md
-
1:00:08
gyn gynecologic and ovarian cancer bcop 2021
-
1:02
dr. sabbatini on the future of dose-dense therapy in ovarian cancer
-
1:15
dr. salani on choosing among iv, ip, and dose-dense chemo regimens in ovarian cancer
-
1:13:59
stanford's dr. oliver dorigo on ovarian cancer -- current & novel treatment strategies
-
25:30
innovative and emerging trials in ovarian cancer
-
0:48
my shocking symptom of ovarian cancer
-
6:12
#esmo19: positive trial for ovarian cancer: velia (gog 3005)
-
1:38
dr. dalton on the standard of care in ovarian cancer
-
1:19
dr. naumann on improving outcomes with chemotherapy in ovarian cancer
-
1:18
dr. sabbatini on frontline treatment of newly diagnosed ovarian cancer
-
1:00:45
expanding the toolkit to fight ovarian cancer: hipec, targeted therapy and beyond
-
2:47
esgo eacademy: adjuvant chemotherapy in low-grade serous ovarian carcinoma
-
8:35
surgical management of advanced ovarian cancer
-
2:03
dr. wenham on trials evaluating ip, iv, and dose-dense chemotherapy in ovarian cancer
-
3:11
ovarian cancer phase iii trial updates: imagyn050 and icon8
-
0:57
new treatment for ovarian cancer | emery salom, md